Arena, Patrick J. http://orcid.org/0000-0003-3024-771X
Dzogang, Camille
Gadoth, Adva
Nkamba, Dalau Mukadi
Hoff, Nicole A.
Kampilu, David
Beia, Michael
Wong, Hui-Lee
Anderson, Steven A.
Kaba, Didine
Rimoin, Anne W.
Article History
Received: 16 June 2022
Accepted: 7 December 2022
First Online: 16 January 2023
Declarations
:
: Institutional review board (IRB) approval was obtained from the University of California, Los Angeles (IRB#19–002150) as well as the Kinshasa School of Public Health at the University of Kinshasa (ESP/CE/300/2019), which served as the local ethics committee. During this retrospective study, no informed consent process took place, as no active participant recruitment or enrollment were performed. All methods were carried out in accordance with relevant guidelines and regulations in the Declaration of Helsinki.
: Not applicable.
: PJA was a part-time contractor for Pfizer, Inc. during the conduct of the study. HLW and SAA are employees of the U.S. Food and Drug Administration, which funded this study. CD, AG, DMN, NAH, DK, MB, DK, and AWR have no competing interests to declare.